Cephalosporins - Fighting Hospital Infections: Case Histories of Transformational Advances

21 Pages Posted: 24 Aug 2020 Last revised: 9 Jun 2021

See all articles by Amar Bhide

Amar Bhide

Columbia University - Mailman School of Public Health

Srikant Datar

Harvard University - Accounting & Control Unit

Katherine Stebbins

Harvard University - Business School (HBS)

Date Written: May 31, 2024

Abstract

This case history describes the development of three generations of cephalosporins – antibiotics that have significantly reduced hospital infections. Specifically, we chronicle how: 1) Early (pre-cephalosporin) antibiotics were developed in the first half of the 20th century. 2) Drug companies developed first-generation cephalosporins in the 1960s using foundational discoveries made by researchers in Italy and the UK in the 1940s and 1950s. 3) Continued modifications of cephalosporin molecules resulted in the second and third generations of the drugs in the 1970s and 1980s.

Suggested Citation

Bhide, Amar and Datar, Srikant and Stebbins, Katherine, Cephalosporins - Fighting Hospital Infections: Case Histories of Transformational Advances (May 31, 2024). Harvard Business School General Management Unit Working Paper No. 20-133, Harvard Business School Accounting & Management Unit Working Paper No. 20-133, Available at SSRN: https://ssrn.com/abstract=3679640 or http://dx.doi.org/10.2139/ssrn.3679640

Amar Bhide

Columbia University - Mailman School of Public Health ( email )

600 West 168th St., 6th Floor
New York, NY 10032
United States

Srikant Datar (Contact Author)

Harvard University - Accounting & Control Unit ( email )

Soldiers Field
Boston, MA 02163
United States
617-495-6543 (Phone)
617-496-7363 (Fax)

Katherine Stebbins

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
83
Abstract Views
1,191
Rank
591,959
PlumX Metrics